)
TG Therapeutics (TGTX) investor relations material
TG Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
The meeting was formally called to order and directors, auditors, and legal counsel were introduced.
The agenda included voting on three items as described in the proxy statement.
Board and executive committee updates
Directors nominated for election included Laurence N. Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Dr. Sagar Lonial, and Michael S. Weiss, to serve until the 2027 annual meeting or until successors are elected.
Shareholder proposals
Three items were presented for shareholder voting: election of directors, ratification of KPMG LLP as auditors for 2026, and an advisory vote on executive compensation.
- Sub-Q launch and label updates aim to drive growth, expand market, and enhance patient experience.TGTX
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - SUB-Q BRIUMVI data signals major market expansion and strong competitive positioning.TGTX
Jefferies Global Healthcare Conference 20263 Jun 2026 - Q1 2026 revenue hit $205M, guidance raised, and liquidity boosted by a $750M loan.TGTX
Q1 202612 May 2026 - Annual meeting to elect directors, ratify auditor, and approve pay, with strong governance focus.TGTX
Proxy filing1 May 2026 - 2025 revenue soared 92% on BRIUMVI growth, with strong 2026 guidance and global expansion.TGTX
Q4 20259 Apr 2026 - Q2 BRIUMVI sales soared 350%+, driving raised guidance, profitability, and new capital moves.TGTX
Q2 20242 Feb 2026 - BRIUMVI's rapid adoption and pipeline expansion position it for CD20 market leadership.TGTX
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Briumvi drives MS market growth, with new patents, pipeline expansion, and a subQ version in development.TGTX
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Briumvi Q3 revenue up 230% year-over-year; full-year guidance raised to $300–$305M.TGTX
Q3 202417 Jan 2026
Next TG Therapeutics earnings date
Next TG Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)